Ndepụta ọgwụ ọjọọ bụ Ceftriaxone bụ ude dị iche iche nke ụdị ọrụ ya dị oke ma gbasaa ụmụ nje microbic na anaerobic, na-adịghị mma nke Gram.
Otu n'ime ihe ngosi maka iji Ceftriaxone bụ ọrịa na-efe efe nke nje ndị a kpatara. Ka anyi leba anya n'uzo zuru oke, na ihe ndi ogwu na enye aka ma otu esi eji ya.
Ojiji nke ceftriaxone na-efe efe
Ọgwụ ọjọọ dị irè megide streptococci nke ìgwè B, C, G, ọlaedo na epidermal staphylococcus, pneumococcus, meningococcus, nsia na hemophilic mkpara, enterobacter, klebsiella, shigella, yersinia, salmonella, proteas, wdg.
Ihe ngosi maka iji ọgwụ Ceftriaxone gụnyere ọrịa na-efe efe site na clostridia, ọ bụ ezie na ọtụtụ nsogbu nke nje a na-eguzogide ọgwụ, actinomycetes, bacteria, peptococci na ụfọdụ anaerobes.
Okwesiri iburu n'obi na ufodu n'ime ihe ndi mmadu edeputara na-egosi iguzogide ọgwụ nje ndi ozo - penicillins, cephalosporins, aminoglycosides, mana Ceftriaxone di irè megide ha.
Kedu ka Ceftriaxone si arụ ọrụ?
Egwu ahụ na-eme bactericidal, ọ bụghị ikwe ka akpụkpọ ahụ nke microorganism mepụta. Mgbe ihe ngosi nke Ceftriaxone na-egosi na ọ bụ injections intramuscularly, ọgwụ ahụ na-egosi absorption zuru ezu na zuru oke, na bioavailability bụ 100% (ọgwụ na-etinye kpamkpam na-enweghị ọnwụ). Otu awa na ọkara mgbe gọọmentị gasịrị, izu nke Ceftriaxone na ahụ ruru n'ogo, ma ọ kachasị dịkarịrị ala mgbe ụbọchị ma ọ bụ karịa.
Ọgwụ ahụ nwere ike ịbanye n'ime mmiri - synovial, pleural, peritoneal, flucratinal fluid and even bone bone. A na-egbochi akụrụgwụ ahụ site na akụrụ ruo ụbọchị abụọ, nakwa na bile site na eriri afọ.
Olee ọrịa ndị Ceftriaxone ga-enyere aka?
Dị ka ntụziaka ahụ si kwuo, ihe ngosi maka iji Ceftriaxone bụ ndị a:
- bronchitis nke nnukwu na-adịghị ala ala ụdị;
- ezughị nke ngụgụ;
- oyi baa;
- streptoderma ;
- nyocha nke arịrịọ;
- nsogbu gonorrhea na-agba mgba;
- cystitis;
- ọrịa gynecological;
- nkwụsị;
- prostatitis;
- peritonitis;
- osteomyelitis;
- meningitis;
- Ọrịa Lyme;
- endocarditis;
- njikọrịta;
- salmonellosis .
N'ime ihe ndị na-egosi, Ceftriaxone nwekwara ọrịa na-arịa ọrịa ndị na-adịghịzi ahụ ike. Jiri ọgwụ na n'oge ịwa ahụ iji gbochie nsogbu nke purulent-septic ọdịdị.
Usoro nke Ceftriaxone
Ọgwụ ahụ n'onwe ya bụ ntụcha ọcha nke a na-akwadebe ihe ngwọta n'ime ụlọ ọgwụgwọ maka nchịkwa nke intramuscular ma ọ bụ nke nchịkwa.
Dị ka usoro, 0.5 g nke ọgwụ na-agbaze na 2 ml mmiri (pụrụ iche, na-adịghị ize ndụ maka ogwu), na 3.5 ml mmiri na-ewere ka igbari 1 g nke ceftriaxone. A na-agbanye ngwaahịa ahụ a nabatara n'ime mmiri ahụ, na-ewebata abịga. Iji belata mgbu, 1% lidocaine nwere ike iji.
Maka injections intravenous, a na-atụgharị ntụ ntụ dị iche iche: 5 ml mmiri ka e weere n'ime 0,5 g ọgwụ ahụ; N'otu oge ahụ, a chọrọ 10 ml mmiri iji tụgharịa 1 g. A na-eme nkedo ahụ nke ọma - maka 2 ruo 4 nkeji. Enweghị ike iji Lidocaine mee ihe.
Ọ bụrụ na ihe ngosi nke Ceftriaxone na-agụnye infusions intravenous (onye na-eri nri), a na-akwadebe ọgwụ ahụ site na 2 g ntụ ntụ na 40 ml nke ihe mgbaze, nke n'aka ya mejupụtara ngwọta nke sodium chloride, glucose, na levulose. Onye na-eri nri dịkarịa ala ọkara otu awa.
Ọgwụgwọ nke ọrịa ahụ na usoro ọgwụgwọ nke ọgwụ ahụ na-ahọrọ nanị site na dọkịta - ogologo oge nke injections ma ọ bụ infusions dabeere na oke na ọrịa nke ọrịa ahụ.